LIGAND PHARMAC.NEW DL-001LIGAND PHARMAC.NEW DL-001LIGAND PHARMAC.NEW DL-001

LIGAND PHARMAC.NEW DL-001

No trades
See on Supercharts

LGDN fundamentals

LIGAND PHARMAC.NEW DL-001 revenue breakdown overview

LIGAND PHARMAC.NEW DL-001 revenue for the last year amounted to 118.97 M EUR, the most of which — 118.97 M EUR — came from its highest performing source at the moment, Biopharmaceutical, the year earlier bringing 183.36 M EUR. The greatest contribution to the revenue figure was made by United States — last year it brought LIGAND PHARMAC.NEW DL-001 118.97 M EUR, and the year before that — 183.36 M EUR.

By source
By country